In situ revascularisation for femoropopliteal graft infection: ten years of experience with silver grafts

Purpose The purpose of this study was to analyze clinical outcome of patients for femoropopliteal graft infection who were treated by in situ reconstruction with a silver-coated prosthesis. Basic methods From December 2001 to December 2011, 27 patients were treated for femoropopliteal graft infection. Twenty patients (74%) were male and seven (26%) were female. Mean age was 65 years. The primary endpoint was recurrence of infection. Secondary endpoints were early and late mortality and morbidity, primary graft patency, major amputation rates and patient survival. Principal findings Early reinfection occurred in 11% and late in 8% of patients. Perioperative mortality was 7% and late was 4%. Above-knee amputation was performed in 4% of patients during early postoperative course and in 12% of patients during follow-up. Early and late graft patency was 96% and 72%, respectively. Conclusions Results of in situ implantation of silver-coated grafts for femoropopliteal prosthesis infection are according to our opinion acceptable, but the risk of reinfection remains.

[1]  G. Moneta.  Aortic reconstruction with femoral-popliteal vein: Graft stenosis incidence, risk and reintervention , 2009 .

[2]  R. Hassen-Khodja,et al.  In-situ revascularisation for patients with aortic graft infection: a single centre experience with silver coated polyester grafts. , 2008, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[3]  Peter Andrew,et al.  A systematic review and meta-analysis of treatments for aortic graft infection. , 2006, Journal of vascular surgery.

[4]  S. Cha,et al.  Evolution from axillofemoral to in situ prosthetic reconstruction for the treatment of aortic graft infections at a single center. , 2006, Journal of vascular surgery.

[5]  D. Cuthbertson,et al.  Graft Infectivity of Rifampin and Silver-Bonded Polyester Grafts to MRSA Contamination , 2005, Vascular and Endovascular Surgery.

[6]  S. Schrag.  The evidence for vascular or endovascular reconstruction , 2004 .

[7]  L. Chiche,et al.  Allograft replacement for infrarenal aortic graft infection: early and late results in 179 patients. , 2004, Journal of vascular surgery.

[8]  J. Magne,et al.  In situ revascularization with silver-coated polyester grafts to treat aortic infection: early and midterm results. , 2003, Journal of vascular surgery.

[9]  M. Back,et al.  Expanded application of in situ replacement for prosthetic graft infection. , 2001, Journal of vascular surgery.

[10]  T. Huber,et al.  Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass grafting and aortic graft removal. , 2000, Journal of vascular surgery.

[11]  J. Hallett,et al.  The results of in situ prosthetic replacement for infected aortic grafts. , 1999, American journal of surgery.

[12]  W. Hawthorne,et al.  An increased concentration of rifampicin bonded to gelatin-sealed Dacron reduces the incidence of subsequent graft infections following a staphylococcal challenge. , 1998, Cardiovascular surgery.

[13]  D. Cooley,et al.  The management of aortoduodenal fistula by in situ replacement of the infected abdominal aortic graft. , 1987, Annals of surgery.